PGT-A
Why opt for this analysis?
Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a technique that allows for the examination of all chromosomes of one or more cells from an embryo conceived through in vitro fertilization.
The primary purpose of this technique is to assess the embryos from an in vitro fertilization cycle to identify those with normal chromosomal makeup, known as Euploids. This, in turn, increases the chances of implantation, pregnancy, and, having a healthy baby.
For whom is it recommended?
This analysis is indicated for patients who have:
- Advanced maternal age.
- History of recurrent miscarriages.
- Repeated implantation failures.
- Severe male factor.
What does this analysis cover?
PGT-A evaluates all chromosomes using next-generation sequencing (NGS) technology.
It is a valuable tool for selecting embryos with a higher likelihood of implantation.
What are its advantages?
PGT-A offers the following benefits:
- Eliminates the influence of maternal age in women.
- Reduces miscarriage rates.
- Reduces the time needed to achieve pregnancy.
- It is essential for obtaining the best results in single embryo transfer (SET) strategy.
- It has been shown to be effective in couples with a good prognosis and a high number of embryos, reducing the number of transfers needed to achieve pregnancy.
